Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.405 CAD -0.01 ( 1.22%)
Last update at 2026-11-04T18:36:00Z
VOLUME
20
Market Cap
48.88M
P/E
20.50

Momentum Score

…

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; and convenience and confectionary products. The company was incorporated in 2021 and is headquartered in Saskatoon, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.41
Low
0.42
High
52 Week Price Range
0.40
Low
0.58
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

PharmaCorp Rx Inc. is a publicly listed company on the TSX Venture Exchange (PCRX.V); public disclosures are limited and operational details are sparse. Future growth would depend on product development progress, regulatory approvals and successful commercialization, which could support revenue if achieved. Investors may find potential upside from milestone-driven value creation but should rely on company filings for specifics.
Principal risks include binary regulatory and clinical outcomes, likely financing and liquidity constraints typical of small-cap pharmaceutical issuers, and competitive and execution risks.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.41
Dividend Yield
-
Revenue TTM
17.60M
Revenue Per Share
0.15
Gross Profit TTM
7.00M
Debt / Equity
-
ROE
0.61%
Net Debt
-
ROCE
-4.74%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31
Income before tax -1.16M -0.47M -0.52M
Net income -1.05M -0.47M -0.52M
Selling general administrative 3.48M 0.58M 0.56M
Gross profit 2.18M 0.00M -
Reconciled depreciation 0.29M 0.00M -
Operating income -1.59M -0.58M -0.56M
Interest expense 0.03M 0.00M -
Tax provision -0.11M 0.00M -
Interest income 0.38M 0.11M 0.05M
Net interest income 0.35M 0.11M 0.05M
Total revenue 5.79M 0.00M 0.00M
Total operating expenses 7.38M 0.58M 0.56M
Cost of revenue 3.61M 0.00M -
Total other income expense net 0.08M - -
Net income from continuing ops -1.05M -0.47M -0.52M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 35.21M 2.32M 2.73M 1.00M
Intangible assets 5.13M - - -
Total liab 4.64M 0.05M 0.02M 0.03M
Total stockholder equity 30.34M 2.27M 2.72M 0.97M
Capital stock 31.70M 2.80M 2.74M 1.00M
Retained earnings -2.03M -1.01M -0.54M -0.03M
Good will 11.48M 0.00M - -
Cash 12.89M 2.24M 2.73M 0.98M
Total current liabilities 1.70M 0.05M 0.02M 0.03M
Short long term debt 0.08M - - -
Total current assets 14.57M 2.32M 2.73M 1.00M
Net receivables 0.33M 0.00M - -
Long term debt 0.32M - - -
Inventory 1.31M 0.00M - -
Accounts payable 1.54M 0.05M 0.02M 0.03M
Non current assets total 20.63M 0.00M 0.00M 0.00M
Capital lease obligations 0.56M 0.00M - -
Breakdown 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31
Investments -16.86M 0.00M -
Total cash from financing activities 27.38M 0.03M 1.87M
Net income -1.05M -0.47M -0.52M
Change in cash 10.64M -0.49M 1.75M
Begin period cash flow 2.24M 2.73M 0.98M
End period cash flow 12.89M 2.24M 2.73M
Total cash from operating activities 0.12M -0.52M -0.12M
Issuance of capital stock 27.33M 0.03M 2.00M
Depreciation 0.29M 0.00M -
Dividends paid - - 0.00M
Capital expenditures 0.01M 0.00M 0.00M
Change in working capital 0.71M -0.05M 0.01M
Stock based compensation 0.28M 0.00M 0.39M
Other non cash items 0.03M - -
Free cash flow 0.12M -0.52M -0.12M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PCRX
PharmaCorp Rx Inc.
-0.01
1.22%
0.41 20.50 41.49 2.78 1.65 2.77 41.56
HITI
High Tide Inc
-0.04
1.02%
3.88 - 45.05 0.46 3.36 0.65 10.91

Profile*

PharmaCorp Rx Inc.

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; and convenience and confectionary products. The company was incorporated in 2021 and is headquartered in Saskatoon, Canada.

303 Wellman Lane, Saskatoon, SK, Canada, S7T 0J1

Name Title Year Born
Mr. Alan A. Simpson Executive Chairperson 1958
Mr. Grady Brown CEO & Director NA
Mr. Calvin LeRoux President & Director NA
Ms. Terri Jean Tatchell Chief Financial Officer NA
Mr. Paul Dale Chief Operating Officer NA
Ms. Kimberly Carroll Corporate Secretary NA
Mr. Paul Dale President & COO NA
Mr. Calvin LeRoux Strategic Advisor to CEO & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…